FANZANI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 7.550
EU - Europa 3.774
AS - Asia 3.378
SA - Sud America 488
Continente sconosciuto - Info sul continente non disponibili 325
AF - Africa 78
OC - Oceania 14
Totale 15.607
Nazione #
US - Stati Uniti d'America 7.376
PL - Polonia 1.202
SG - Singapore 1.181
CN - Cina 1.104
IT - Italia 667
UA - Ucraina 514
BR - Brasile 393
DE - Germania 383
HK - Hong Kong 338
GB - Regno Unito 251
FI - Finlandia 236
VN - Vietnam 193
FR - Francia 150
IN - India 137
TR - Turchia 108
RU - Federazione Russa 99
IE - Irlanda 89
BD - Bangladesh 81
CA - Canada 81
JP - Giappone 45
MX - Messico 37
AR - Argentina 32
ID - Indonesia 30
IQ - Iraq 30
NL - Olanda 28
CZ - Repubblica Ceca 27
ES - Italia 24
SA - Arabia Saudita 22
ZA - Sudafrica 22
SE - Svezia 21
BE - Belgio 19
CO - Colombia 16
EC - Ecuador 16
EG - Egitto 14
AU - Australia 13
VE - Venezuela 13
AT - Austria 12
NI - Nicaragua 12
UZ - Uzbekistan 11
JM - Giamaica 10
KE - Kenya 9
NG - Nigeria 9
CH - Svizzera 8
IR - Iran 8
KR - Corea 8
PK - Pakistan 8
AE - Emirati Arabi Uniti 7
KZ - Kazakistan 7
MA - Marocco 7
MY - Malesia 7
TT - Trinidad e Tobago 7
AL - Albania 6
PA - Panama 6
BB - Barbados 5
DZ - Algeria 5
JO - Giordania 5
PY - Paraguay 5
TH - Thailandia 5
CR - Costa Rica 4
DK - Danimarca 4
EE - Estonia 4
EU - Europa 4
KG - Kirghizistan 4
LT - Lituania 4
LV - Lettonia 4
OM - Oman 4
PE - Perù 4
PH - Filippine 4
TW - Taiwan 4
CL - Cile 3
HN - Honduras 3
IL - Israele 3
LA - Repubblica Popolare Democratica del Laos 3
MU - Mauritius 3
PT - Portogallo 3
RO - Romania 3
SI - Slovenia 3
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
GY - Guiana 2
HU - Ungheria 2
KW - Kuwait 2
LB - Libano 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
TN - Tunisia 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
Totale 15.268
Città #
Warsaw 1.200
Ashburn 710
Singapore 623
Fairfield 620
Woodbridge 508
San Jose 503
Jacksonville 372
Hong Kong 335
Houston 310
Beijing 250
Cambridge 243
Seattle 236
Brescia 230
Wilmington 219
Chandler 218
Council Bluffs 201
New York 200
Ann Arbor 193
The Dalles 179
Los Angeles 169
Princeton 157
Chicago 136
Nanjing 132
Helsinki 129
Lauterbourg 92
Lancaster 91
Dublin 89
Istanbul 85
Columbus 77
Milan 75
Buffalo 67
Munich 66
Dearborn 62
Dallas 59
Jinan 56
Des Moines 55
Salt Lake City 55
Shenyang 51
Nanchang 48
Ho Chi Minh City 45
Hanoi 44
Shanghai 44
San Francisco 43
Santa Clara 40
Hebei 38
Redondo Beach 36
Moscow 35
Tianjin 35
Dong Ket 34
Changsha 33
Phoenix 33
Elk Grove Village 32
Turku 30
Verona 30
Brooklyn 29
Orem 29
San Diego 29
London 26
São Paulo 26
Jakarta 25
Atlanta 24
Denver 24
Rome 24
Toronto 23
Boston 22
Tampa 22
Ningbo 20
Hangzhou 19
Taizhou 18
Brussels 17
Frankfurt am Main 17
Montreal 17
Stockholm 17
Baghdad 16
Manchester 16
Nuremberg 16
Tokyo 16
Johannesburg 15
New Delhi 15
Olomouc 15
Urbino 15
Zhengzhou 15
Boardman 14
Charlotte 14
Chennai 14
Dhaka 14
Kunming 14
Ottawa 14
Poplar 14
Salerno 14
Mexico City 13
Miami 13
Managua 12
San Mateo 12
Taiyuan 12
Washington 12
Brno 11
Guangzhou 11
Lappeenranta 11
Norwalk 11
Totale 10.450
Nome #
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 602
Inhibition of glutathione peroxidase 4 primes mouse C2C12 myoblasts and rhabdomyosarcoma cell lines to ferroptosis 352
Characterization of the AP-1 μ1A and μ1B adaptins in zebrafish (Danio rerio) 321
Caveolin-3, MURC and Trim72 predict myogenic differentiation in the human embryonal rhabdomyosarcoma RD cell line 293
Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma. 292
Caveolin-1 overexpression in the human embryonal rhabdomyosarcoma RD cells increases tumor growth and metastasis in vivo through a phospho-ERK-dependent signaling pathway 280
Melatonin action in tumor skeletal muscle cells: an ultrastructural study 270
Caveolin-1 overexpression accelerates tumor growth and metastasis of embryonal rhabdomyosarcoma 267
Intake of Special Amino Acids Mixture Leads to Blunted Murine Colon Cancer Growth In Vitro and In Vivo 257
Caveolin-1, Caveolin-2 and Cavin-1 are strong predictors of adipogenic differentiation in human tumors and cell lines of liposarcoma 232
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 226
Urocortin Induces Phosphorylation of Distinct Residues of Signal Transducer and Activator of Transcription 3 (STAT3) via Different Signaling Pathways 216
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 211
Caveolin 1 is a marker of poor differentiation in Rhabdomyosarcoma 207
Melatonin effects in normal and tumoral skeletal muscle cells: a preliminary study 206
Cobalt triggers necrotic cell death and atrophy in skeletal C2C12 myotubes 205
Erastin is a strong inducer of ferroptosis in human rhabdomyosarcoma cell lines 203
The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells 203
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 201
Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines 198
Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems 194
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 192
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation 191
Caveolin-1-overexpression induces deep plasma membrane rearrangement and secretion of extracellular vesicles in a model of rhabdomyosarcoma 181
The cytosolic sialidase Neu2 is degraded by autophagy during myoblast atrophy. 179
Cytosolic sialidase Neu2 upregulation during PC12 cells differentiation. 178
Implications for the mammalian sialidases in the physiopathology of skeletal muscle 178
Animal models of well-differentiated/dedifferentiated liposarcoma: utility and limitations 177
Rhabdomyosarcomas: an overview on the experimental animal models. 174
Hypertrophy and atrophy inversely regulate Caveolin-3 expression in myoblasts 171
Point mutated Caveolin-3 form (P104L) impairs myoblast differentiation via Akt and p38 signalling reduction, leading to an immature cell signature 169
CAVEOLIN-1 IS A MARKER OF POOR DIFFERENTIATION IN RHABDOMYOSARCOMA 167
Defective myogenic differentiation of human rhabdomyosarcoma cells is characterized by sialidase Neu2 loss of expression. 163
Biochemical characterization of Neu2, a novel human cytosolic sialidase 163
Molecular and cellular mechanisms of skeletal muscle atrophy: an update 161
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair 161
The enzymatic activity of sialidase Neu2 is inversely regulated during in vitro myoblast hypertrophy and atrophy. 160
Phenotypic behavior of C2C12 myoblasts upon expression of the dystrophy-related caveolin-3 P104L and TFT mutants 160
Overexpression of cytosolic sialidase Neu2 induces myoblast differentiation in C2C12 cells. 159
Autophagic degradation contributes to muscle wasting in cancer cachexia 158
Uncovering metabolism in rhabdomyosarcoma 158
Clozapine-induced alteration of glucose homeostasis in the rat: the contribution of hypothalamic-pituitary-adrenal axis activation 157
Caveolins in rhabdomyosarcoma 157
Insulin-like growth factor 1 signaling regulates cytosolic sialidase Neu2 expression during myoblast differentiation and hypertrophy. 155
Cavin-2 is a specific marker for detection of well-differentiated liposarcoma. 154
Caveolin-1-overexpression induces extracellular vesicle secretion in a model of rhabdomyosarcoma 154
OVEREXPRESSION OF CYTOSOLIC SIALIDASE NEU2 INDUCES MYOBLAST DIFFERENTIATION IN C2C12 CELLS 152
Focus on the role of Caveolin and Cavin protein families in liposarcoma 148
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 148
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma 146
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 146
Intracellular vesicular traffic:cloning, expression and antisense inhibition of AP1m1 subunit ortholog in zebrafish 145
Validation of PTRF/cavin-1 expression and plasma membrane association with caveolin-1 in human cell lines and mouse primary tumor cultures of rhabdomyosarcoma 145
Design and optimization of lentiviral vectors for transfer of galc expression in twitcher brain 142
AUTOPHAGIC DEGRADATION CONTRIBUTES TO MUSCLE WASTING IN CANCER CACHEXIA 141
Melatonin decreases cell proliferation, impairs myogenic differentiation and triggers apoptotic cell death in rhabdomyosarcoma cell lines 141
Downregulation of Zebrafish Cytosolic Sialidase Neu3.2 Affects Skeletal Muscle Development 140
CAVEOLINS AND CAVINS IN MUSCLE-DERIVED TUMOURS 138
OVEREXPRESSION OF CYTOSOLIC SIALIDASE NEU2 INDUCES MYOBLAST DIFFERENTIATION IN C2C12 CELLS 137
Muscular dystrophies share pathogenetic mechanisms with muscle sarcomas 137
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance 135
Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization 135
Guidelines for the use and interpretation of assays for monitoring autophagy 133
Generation and characterization of chemoresistant embryonal rhabdomyosarcoma RD line 132
Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition. 131
IGF-I SIGNALING REGULATES CYTOSOLIC SIALIDASE NEU2 DURING MYOBLAST HYPERTROPHY. 125
Involvment of sialidases in differentation of PC12 123
CAVEOLIN-1 PROMOTES PROLIFERATION AND CONFERS RESISTANCE TO OXIDATIVE STRESS-INDUCED CELL DEATH IN RHABDOMYOSARCOMA CELLS 123
The cytosolic sialidase Neu2 is substrate of degradation by autophagy during myoblast atrophy 119
DORSOMORPHIN, A SELECTIVE INHIBITOR OF SMAD1/5/8 PHOSPHORYLATION, IS A POTENT ENHANCER OF MYOBLAST DIFFERENTIATION 119
IGF-I INDUCED HYPERTROPHY OF MYOBLASTS INCREASES CYTOSOLIC SIALIDASE NEU2 THROUGH PI-3 KINASE/AKT/mTOR PATHWAY. 116
Nanostructured Hybrid Polymer-Lipid Drug Delivery Platforms for Rapamycin Repositioning in Anticancer Therapy 111
The expression of Caveolin-3 and its related Limb Girdle Muscular Dystrophy 1-c mutants in myoblasts: physiological and pathological aspects 111
Differentiation of human rhabdomyosarcoma RD cells is regulated by reciprocal, functional interactions between myostatin, p38 and ERK signalling pathways 110
Intracellular vesicular traffic: identification and expression of zebrafihs APM1 during zebrafish development 109
Developmental expression of the sialidase Neu2 ortholog gene in zebrafish and characterization of the knock-down model. 109
L6E9 Myoblasts Are Deficient of Myostatin and Additional TGF-βMembers Are Candidates to Developmentally Control Their FiberFormation 108
The chemotherapic compound cisplatin causes myotube atrophy by increment of proteasoma activation. 106
INDUCTION OF MYOBLAST DIFFERENTIATION BY THE CYTOSOLIC SIALIDASE NEU2 OVEREXPRESSION 105
Downregulation of Zebrafish Cytosolic Sialidase Neu3.2 Affects Skeletal Muscle Development 104
FUNCTIONAL ANTAGONISM BETWEEN P38 AND MYOSTATIN PATHWAYS IN RHABDOMYOSARCOMA CELLS 99
Expression of a myrystoilated Akt1 isoform in rhabdomyosarcoma cells promotes chemo and radioresistance, but confers marked susceptibility to metabolic drug inhibitors 93
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 92
Essential Amino Acids-Rich Diet Decreased Adipose Tissue Storage in Adult Mice: A Preliminary Histopathological Study 91
THE MISSENSE CAV-3/P104L MUTATION, INVOLVED IN THE ONSET OF LIMB GIRDLE MUSCULAR DYSTROPHY 1-C, CONFERS AN IMMATURE SIGNATURE TO C2C12 MYOBLASTS 88
miR-449a/miR-340 reprogram cell identity and metabolism in fusion-negative rhabdomyosarcoma 83
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo 81
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation 81
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks 79
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 79
Advances in Nanoparticle Systems for Targeted Therapy against Glioblastoma Multiforme 77
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 77
MS-275 (Entinostat) Promotes Radio-sensitivity in PAX3-FOXO1 Rhabdomyosarcoma cells 71
Phospholipase Cδ-4 (PLCδ4) Acts as a Nuclear Player to Influence Cyclin B Expression in the Embryonal Rhabdomyosarcoma Cell Lines RD and A204 69
The modulation of iron metabolism affects the Rhabdomyosarcoma tumor growth in vitro and in vivo 65
Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma 64
Statin-Sensitive Akt1/Src/Caveolin-1 Signaling Enhances Oxidative Stress Resistance in Rhabdomyosarcoma 63
Radioresistance in rhabdomyosarcomas: Much more than a question of dose 61
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation 60
Synthetic inhibition of the SUMO pathway by targeting the SAE1 component via TAK-981 compound impairs growth and chemosensitizes embryonal and alveolar rhabdomyosarcoma cell lines 44
Totale 15.500
Categoria #
all - tutte 65.724
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.724


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022509 0 0 0 14 6 22 48 37 27 97 95 163
2022/2023693 87 24 31 41 60 165 5 63 112 10 39 56
2023/2024817 55 13 108 41 42 159 26 43 177 21 15 117
2024/20252.339 39 10 32 254 197 138 144 62 245 104 832 282
2025/20264.117 405 470 228 511 497 280 696 197 244 332 183 74
2026/2027820 152 169 396 103 0 0 0 0 0 0 0 0
Totale 15.607